Overview
Location
France
Total raised
$165M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 22, 2026 | Bionyra Pharma Raises $165 Million Series A To Advance Biologics For Inflammatory Diseases | Bionyra Pharma announced its launch and an oversubscribed $165 million Series A financing round. The round was co-led by Jeito Capital and Sofinnova Partners. Arkin Bio, Sanofi Ventures, Sixty Degree Capital, Vives Partners, and Apollo Heal... |
| Jun 22, 2026 | Bionyra Pharma Raises $165M to Advance Next-Generation Immune Disease Treatments | Bionyra Pharma Launches With $165M Series A Financing Bionyra Pharma, a clinical-stage biotech, is taking flight out of stealth after raising $165 million Series A funding to advance a portfolio of biologic drugs designed to treat immune-me... |
| Jun 22, 2026 | Bionyra Pharma Raises $165M in Series A Funding | Bionyra Pharma, a Paris, France- and Boston, MA-based clinical-stage biopharmaceutical company developing new biologics for immune-mediated inflammatory diseases, raised $165M in Series A funding. The round was led by Jeito Capital and Sofi... |
| Bionyra |